Logan D. Andrews

机构：23andMe (United States) · ORCID：0000-0002-5092-4530

发表论文 18 篇 · 总被引 680 次 · h-index 13

代表论文

• Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation (2018 · EcoSal Plus · 被引 199)
• Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety (2019 · ChemMedChem · 被引 77)
• Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa (2019 · Antimicrobial Agents and Chemotherapy · 被引 62)
• Characterization of a novel bacterial arginine kinase from Desulfotalea psychrophila (2008 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · 被引 47)
• Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety. (2019 · PubMed · 被引 44)
• Ground State Destabilization by Anionic Nucleophiles Contributes to the Activity of Phosphoryl Transfer Enzymes (2013 · PLoS Biology · 被引 40)